Cargando…

Patient Alerting Features in Implantable Defibrillators

Detalles Bibliográficos
Autores principales:	Vollmann, Dirk, Zabel, Markus, Francis, Johnson
Formato:	Texto
Lenguaje:	English
Publicado:	Indian Heart Rhythm Society 2008
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2231606/ https://www.ncbi.nlm.nih.gov/pubmed/18270597

Ejemplares similares

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005)

Vibratory alert in a recalled implantable cardioverter-defibrillator: Is there something wrong with the device?
por: Ortman, Matthew
Publicado: (2017)

Impact of an Automated Best Practice Alert on Sex and Race Disparities in Implantable Cardioverter‐Defibrillator Therapy
por: Thalappillil, Alvin, et al.
Publicado: (2022)

An implantable defibrillator and what else?
por: Mont, Lluís, et al.
Publicado: (2009)

Quality of Life in Patients with Implantable Cardioverter Defibrillators
por: Francis, Johnson, et al.
Publicado: (2006)

Quality of Life in Patients with an Implantable Cardioverter Defibrillator: A Systematic Review
por: Tomzik, Juliane, et al.
Publicado: (2015)

The first cardioverter defibrillator implanted in Central Africa
por: Cabral, Tantchou Tchoumi Jacques, et al.
Publicado: (2016)

Should mechanical dyssynchrony be assessed in patients with implantable cardioverter-defibrillators?
por: Boogers, Mark J., et al.
Publicado: (2010)

Failure of Lead Integrity Alert to detect implantable cardioverter-defibrillator lead-system failure in a pacemaker-dependent patient
por: Kella, Danesh K., et al.
Publicado: (2020)

Do elderly patients benefit from implantable-cardioverter defibrillators?
por: de Groot, J. R.
Publicado: (2014)

Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
por: Frommeyer, Gerrit, et al.
Publicado: (2016)

Diagnostic tests to predict outcome in patients with implantable cardioverter defibrillators: it is not that simple!
por: Maass, A. H.
Publicado: (2014)

Myopotential oversensing notified by Lead Integrity Alert in a patient with implantable cardioverter defibrillator with a dedicated bipolar epicardial sensing lead
por: Yazaki, Kyoichiro, et al.
Publicado: (2016)

Reuse Potential of Pacemakers and Implantable Cardioverter-defibrillators - Some Real World Data
por: Abhilash, SP, et al.
Publicado: (2013)

Implantable cardioverter-defibrillator in patients awaiting heart transplantation: Reinforcing the bridge to transplant
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2021)

The Subcutaneous Implantable Cardioverter-defibrillator: New Features and Implant Techniques and Future Developments
por: Zeineh, Nabil S., et al.
Publicado: (2018)

Implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with epicardial defibrillation patches
por: Yoshizawa, Reisuke, et al.
Publicado: (2021)

Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis
por: Dornquast, Christina, et al.
Publicado: (2020)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Gulf Implantable Cardioverter-defibrillator Registry Reflects Advanced Cardiac Care in the Arab Gulf
por: Albinali, Hajar A.
Publicado: (2015)

Renal artery ablation instead of pulmonary vein ablation in a hypertensive patient with symptomatic, drug-resistant, persistent atrial fibrillation
por: Vollmann, Dirk, et al.
Publicado: (2012)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
por: Malhotra, Rakesh, et al.
Publicado: (2017)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Alert system-supported lay defibrillation and basic life-support for cardiac arrest at home
por: Stieglis, Remy, et al.
Publicado: (2021)

Paradox of Appropriate Implantable Cardioverter‐Defibrillator Therapy: Saving Lives But Revealing an Increased Mortality Risk
por: Aleong, Ryan G., et al.
Publicado: (2017)

Internal cardioversion of persistent atrial fibrillation in implantable cardioverter defibrillator patients: the juice is not worth the squeeze
por: Berger, W. R., et al.
Publicado: (2013)

Subcutaneous defibrillator implantation in pediatric patients
por: Ertuğrul, İlker, et al.
Publicado: (2016)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Loss of capture late after right ventricular pacing lead revision: what is the mechanism?
por: Seegers, Joachim, et al.
Publicado: (2009)

Who benefits from implantable cardioverter defibrillator therapy, and who pays the price?
por: Olde Nordkamp, L. R. A., et al.
Publicado: (2013)

Preventing Sudden Death with Implantable Defibrillators in Octogenarians: Too Much Too Late?
por: John, Roy M.
Publicado: (2016)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Prevalence of Echocardiographic Features Suggesting Cardiac Sarcoidosis in Patients With Pacemaker or Implantable Cardiac Defibrillator
por: Sun, Byung Joo, et al.
Publicado: (2011)

Azygos Vein Lead Implantation For High Defibrillation Thresholds In Implantable Cardioverter Defibrillator Placement
por: Kommuri, Naga VA, et al.
Publicado: (2010)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

Editorial to implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
por: Minamiguchi, Hitoshi
Publicado: (2019)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mj42ql0av00uvngov9eu7f02or